On the other hand, Kupffer cells may protect the tissues by secretion of anti-inflammatory cytokines including IL-10
On the other hand, Kupffer cells may protect the tissues by secretion of anti-inflammatory cytokines including IL-10. this disparity[4]. Ischemia-reperfusion injury (IRI) causes a spectrum of early organ dysfunction after transplantation; the most severe form, termed primary non-function, may result in patient death. Marginal organs, including those from older donors, those affected by steatosis and those from donors with long pre-donation intensive care unit stay, may be judged to pose an excessive risk of IRI and be discarded, placing additional pressure on the already scarce donor resource[5]. Due to shifting patterns of organ donation, there is a tendency towards increased use of marginal organs. 12 months on 12 months, the mean donor age is increasing, in part due to improvements in road safety and declining numbers of traumatic deaths. Furthermore, NHBD (also termed donation after cardiac death) is becoming an increasingly important component of the donor resource[6]. Compared with the gold standard of heart beating donation (HBD), NHBD is usually associated with a decreased quantity of donated organs (2.1 organs per donor compared with 3.4 organs per HBD). Albeit in small studies, NHBD liver transplantation is R428 also associated with a higher risk of IRI leading to elevated incidence of primary non-function[7]. Our group has Terlipressin Acetate previously estimated that negating the effects of IRI in HBD would lead to a 6% increase in the donor supply through recruitment of these marginal organs back into the donor pool[4]. In the current climate of rapidly increasing NHBD and increasing donor age, the imperative to better understand and avert hepatic ischemia is becoming ever stronger. == DEFINITION OF IRI == Interruption of blood flow to any tissue results in inadequate tissue oxygenation and an increase in cellular anaerobic pathways: if adequate oxygenation is not restored then disruption of cellular functions and cell death results. On reperfusion, despite restoration of adequate cellular oxygenation, there is further damage caused both by direct cytotoxicity from oxygen free radicals (OFR)[8] and by R428 a secondary immunological assault upon the injured organ involving components of both the innate and adaptive immune system[9]. The sequence of injuries resulting from interruption then reinstatement of blood flow is usually termed IRI. == HEME OXYGENASE-1 == Heme oxygenase (HO) is usually a nicotinamide adenine dinucleotide phosphate (NADPH)-dependent microsomal enzyme, which catalyzes the breakdown of heme to biliverdin, iron and carbon monoxide (CO)[10] (Physique1). Biliverdin is usually subsequently reduced to bilirubin by biliverdin reductase while free iron is usually sequestrated by ferritin. R428 Of the three heme oxygenase isoforms (HO-1, HO-2 and HO-3), only HO-1 (also known as heat shock protein 32) is usually inducible[11]. HO-1 is usually a 32 kDa enzyme encoded by thehmox1gene. It has been found to be upregulated during says of oxidative and cellular stress and plays an important role in maintaining oxidative/antioxidant homeostasis[12]. == Physique 1. == Putative mechanisms of heme oxygenase-1 antioxidant effect. HO-1: Heme oxygenase-1; BVR: Biliverdin; OFR: Oxygen free radicals; NADPH: Nicotinamide adenine dinucleotide phosphate. Induction R428 of HO-1 and its metabolites is protective in a large number of seemingly unrelated pathologies, including sepsis, malaria, endotoxic shock, IRI, organ transplant rejection, induction of tolerance, myocardial infarction, type 2 diabetes and obesity[13]. R428 This spectrum of protection is usually attributed to multi-level mechanisms of cytoprotection and inflammatory modulation. Polymorphism in the (GT)n microsatellite of theHMOX1promoter is usually thought to be responsible for the variations seen in the human response.
